Ascentage Pharma Group Corporation Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ascentage Pharma Group Corporation's estimated annual revenue is currently $29.3M per year.(i)
  • Ascentage Pharma Group Corporation's estimated revenue per employee is $201,000

Employee Data

  • Ascentage Pharma Group Corporation has 146 Employees.(i)
  • Ascentage Pharma Group Corporation grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M35-24%N/AN/A
#2
$3M36-8%N/AN/A
#3
$11.3M5624%N/AN/A
#4
$265.3M132019%N/AN/A
#5
$24.7M12332%N/AN/A
#6
$85.4M4250%N/AN/A
#7
$10.7M5329%N/AN/A
#8
$29.3M14625%N/AN/A
#9
$21.1M10521%N/AN/A
#10
$2.6M3172%N/AN/A

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company's expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.

keywords:N/A

N/A

Total Funding

146

Number of Employees

$29.3M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascentage Pharma Group Corporation News

2022-04-13 - Global Small-cell Lung Cancer Pipeline Insight | Clinical Trials ...

In March 2022, Luye Pharma Group announced that it has filed a New ... In March 2022, Harpoon Therapeutics, Inc. announced that the U.S....

2022-03-30 - Innovent Announced 2021 Annual Results

The global product development team expansion and infrastructure ... co-development and co-commercialization with Ascentage Pharma in China.

2022-03-22 - Ascentage Pharma Announces 2021 Annual Results with ...

To date, Ascentage Pharma has built a commercialization team possessing ... Inc. ("Pfizer) to evaluate the combination of Ascentage Pharma's...

2019-08-26 - Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand ...

Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.

2019-08-15 - Global Bcl-2-Like Protein 1 Market Analysis, Size, Share ...

Global Bcl-2-Like Protein 1 Market Analysis, Size, Share, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.3M1480%N/A
#2
$16.4M149N/AN/A
#3
$22.6M1508%$21.1M
#4
$23.3M15118%N/A
#5
$35.4M155-1%N/A